[HTML][HTML] Gastrointestinal manifestations of COVID-19: a review of what we know
A Groff, M Kavanaugh, D Ramgobin… - Ochsner …, 2021 - ochsnerjournal.org
Background: The coronavirus disease 2019 (COVID-19) is not just a disease of the
respiratory system. The virus can affect the gastrointestinal (GI) tract as well. Recognizing …
respiratory system. The virus can affect the gastrointestinal (GI) tract as well. Recognizing …
Molecular consequences of SARS-CoV-2 liver tropism
N Wanner, G Andrieux, P Badia-i-Mompel, C Edler… - Nature …, 2022 - nature.com
Extrapulmonary manifestations of COVID-19 have gained attention due to their links to
clinical outcomes and their potential long-term sequelae. Severe acute respiratory syndrome …
clinical outcomes and their potential long-term sequelae. Severe acute respiratory syndrome …
Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in patients with chronic liver disease
Progressive cholestasis and associated sclerosing cholangiti... : Hepatology Progressive
cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in …
cholestasis and associated sclerosing cholangitis are frequent complications of COVID‐19 in …
[HTML][HTML] COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
P Li, Y Liu, Z Cheng, X Yu, Y Li - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
syndrome coronavirus-2 (SARS-CoV-2), has become a global epidemic and poses a major …
Risk of acute liver injury following the mRNA (BNT162b2) and inactivated (CoronaVac) COVID-19 vaccines
Background & Aims Case reports of severe acute liver injury (ALI) following COVID-19
vaccination have recently been published. We evaluated the risks of ALI following COVID-19 …
vaccination have recently been published. We evaluated the risks of ALI following COVID-19 …
Drug-induced liver injury in COVID-19 patients: a systematic review
F Sodeifian, ZS Seyedalhosseini, N Kian… - Frontiers in …, 2021 - frontiersin.org
Introduction: The severity of COVID-19 may be correlated with the risk of liver injury
development. An increasing number of studies indicate that degrees of hepatotoxicity has …
development. An increasing number of studies indicate that degrees of hepatotoxicity has …
Diverse immunological factors influencing pathogenesis in patients with COVID-19: a review on viral dissemination, immunotherapeutic options to counter cytokine …
AA Rabaan, SH Al-Ahmed, MA Garout, AM Al-Qaaneh… - Pathogens, 2021 - mdpi.com
The pathogenesis of coronavirus disease 2019 (COVID-19), caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …
respiratory syndrome coronavirus 2 (SARS-CoV-2), is still not fully unraveled. Though …
Acute liver failure guidelines
A Shingina, N Mukhtar, J Wakim-Fleming… - Official journal of the …, 2023 - journals.lww.com
Acute liver failure (ALF) is a rare, acute, potentially reversible condition resulting in severe
liver impairment and rapid clinical deterioration in patients without preexisting liver disease …
liver impairment and rapid clinical deterioration in patients without preexisting liver disease …
Secondary sclerosing cholangitis as cause of persistent jaundice in patients with severe COVID‐19
S Bütikofer, D Lenggenhager… - Liver …, 2021 - Wiley Online Library
Abstract Background & Aims Little is known about cholestasis, including its most severe
variant secondary sclerosing cholangitis (SSC), in critically ill patients with coronavirus …
variant secondary sclerosing cholangitis (SSC), in critically ill patients with coronavirus …